At the recent American Association of Clinical Endocrinology annual meeting, experts shared updates on the complexities of diagnosing and managing Cushing's disease, including novel drug strategies and real-world challenges with access to care.

In this MedPage Today video, Ricardo Correa Marquez, MD, of the Cleveland Clinic, outlines key takeaways from the session, including emerging therapies targeting adrenocorticotropic hormone (ACTH), the role of combination treatments, and the ongoing struggle with insurance authorization.

Following is a transcript of his remarks :

So I thought that the lecture was really on target on the new updates in Cushing's. So not just in the screening part, because it's not an easy disease; it's not like having an A1C where you can make a diagnosis of

See Full Page